K. Fontaine

发表

miR-31 as a prognostic and predictive marker of disease-free survival (DFS) in resected stage III colon cancer: A retrospective analysis of the PETACC-8 trial.

P. Laurent-Puig, C. Lepage, S. Martin-Lannerée, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

A scoring strategy combining statistics and functional genomics supports a possible role for common polygenic variation in autism

G. Dawson, G. Schellenberg, A. Hardan, 2014, Front. Genet..

Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy

Sabine Tejpar, Bruno Landi, Simona Rossi, 2014, Clinical Cancer Research.

Mir-31-3p as a predictive biomarker of cetuximab effects in a post hoc analysis of new EPOC phase III trial.

S. Imbeaud, P. Laurent-Puig, J. Bridgewater, 2014 .

Evaluation of miR 31 3p as a biomarker of prognosis and panitumumab benefit in RAS-wt advanced colorectal cancer (aCRC): Analysis of patients (pts) from the PICCOLO trial.

P. Laurent-Puig, P. Quirke, D. Vernerey, 2015 .

Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressiva.

C. Daviaud, C. Ayuso, K. Fontaine, 2001, American journal of medical genetics.

Localization of the gene for fibrodysplasia ossificans progressiva (FOP) to chromosome 17q21-22.

G. Lenoir, K. Fontaine, G. Lucotte, 2000, Genetic counseling.

Convergent evidence identifying MAP/microtubule affinity-regulating kinase 1 (MARK1) as a susceptibility gene for autism.

P. Gorwood, N. Ramoz, A. Chédotal, 2008, Human molecular genetics.

Association of autism with polymorphisms in the paired-like homeodomain transcription factor 1 (PITX1) on chromosome 5q31: a candidate gene analysis

A. Philippi, J. Hager, P. Gesnouin, 2007, BMC Medical Genetics.

Predictive Biomarkers and Personalized Medicine Hsa-miR-31-3 p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy

S. Imbeaud, S. Rossi, S. Knuutila, 2014 .

Haplotypes in the gene encoding protein kinase c-beta (PRKCB1) on chromosome 16 are associated with autism

A. Philippi, J. Hager, J. Saraiva, 2005, Molecular Psychiatry.

MiR 31 3p as a predictive biomarker of cetuximab efficacy effect in metastatic colorectal cancer (mCRC) patients enrolled in FIRE-3 study.

P. Laurent-Puig, V. Heinemann, F. Bonnetain, 2016 .

A new mutation of the noggin gene in a French Fibrodysplasia ossificans progressiva (FOP) family.

G. Lenoir, K. Fontaine, G. Lucotte, 2005, Genetic counseling.

Technical Validation of a Reverse-Transcription Quantitative Polymerase Chain Reaction In Vitro Diagnostic Test for the Determination of MiR-31-3p Expression Levels in Formalin-Fixed Paraffin-Embedded Metastatic Colorectal Cancer Tumor Specimens

S. Martin-Lannerée, C. Vazart, K. Fontaine, 2018, Biomarker insights.

Association of microRNA-21 with efficacy of cetuximab in RAS wild-type patients in the FIRE-3 study (AIO KRK-0306) and microRNA-21’s influence on gene expression in the EGFR signaling pathway.

W. Scheithauer, V. Heinemann, S. Al-Batran, 2019, Journal of Clinical Oncology.